In Vitro and in Vivo Anti-Tumor Effects of Brexpiprazole, a Newly-Developed Serotonin-Dopamine Activity Modulator With an Improved Safety Profile
Oncotarget - United States
doi 10.18632/oncotarget.26949
Full Text
Open PDFAbstract
Available in full text
Date
May 10, 2019
Authors
Unknown
Publisher
Impact Journals, LLC